5. DKA - Management
Fluid resuscitation
1L first 30min
1L next hour
1L over next 2 hours
Then fluids to rehydrate
Fluids fluids fluids!
If Na rise >2.4mmol/l for each 5.5mmol/l fall in BSL = insufficient fluid replacement
No evidence for Hartmann’s, nil evidence to support benefit compared to NS
Needs regular review to avoid overload
Shouldn’t delay giving K+
6. DKA - Management
Insulin
50iu actrapid in 500mL NS @ 40ml/hr
Aim for 3-5 mmol/L per hour drop in BSL
10% dextrose when BSL 10-15mmol
Maintain infusion until acidosis corrected
Stop when eating normally and change to S/C
To be stopped 1hr after s/c dose administered and meal ingestion
BSL rising with tx likely is related to pump failure
7. DKA - Management
Cochrane Review re: S/C vs IV insulin for DKA (21/1/16)
5 RCTs, n = 201
Time to resolution of DKA between s/c and IV did not differ substantially
Hypoglycaemic episodes similar between groups
http://onlinelibrary.wiley.com.qelibresources.health.wa.gov.au/doi/10.1002/14651858.CD011281.pub2/full
8. DKA - Management
Potassium
K <3.5 = 40mmol/l per hour
K 3.5-5.5 = 20mmol/l per hour
K > 5.5 = hold
If nil urine output, refrain from administering K+
Insulin mediated potassium uptake
9. DKA - Management
Bicarbonate
Controversial
Has been associated with hypokalemia, decreased tissue oxygen uptake,
cerebral oedema, delay to resolution of DKA
pH <6.9 may benefit to avoid adverse effects of severe acidosis, such as
impaired myocardial contractility
100mmol in 400ml NS with 20mEq KCl @ 200ml/hr for 2 hours until pH >7
Not recommended in HHS
Isn’t in SCGH’s protocol
10. DKA - Monitoring
Fluid balance chart with hourly urine output
IDC if unable to reliably measure
NGT if vomiting and drowsy
Repeat labs
Check 1 hour after therapy initation, then 2-6 hourly until fixed
BSL/VBG/ketones
Hourly obs
12. HHS - Management
Fluid resuscitation
1L first 2hrs
1L next 2-4hrs
1L over 4-6hrs
Then fluids to rehydrate
Careful not to overhydrate!
Avoid overhydration and too rapid of a fall of BSL (hypotension)
13. HHS - Management
Insulin
50iu actrapid in 500mL NS @ 40ml/hr
Aim for 3-5 mmol/L per hour drop in BSL
10% dextrose when BSL 10-15mmol
FSH protocol
Treat hyperglycemia with IVF only
When BSL stops falling with IVF or if ketonemia >1mmol/L, commence insulin
14. HHS - Management
Potassium
K < 5.4 = 40mmol/l per hour
K >5.4 = hold
Anticoagulation
Higher risk of thromboembolic adverse events
Severe dehydration/hypertonicity results in disruption of endothelial cells
Release of thromboplastins, elevated vasopressin = enhanced coagulation
Overall incidence 1.7% (modestly lower than in ortho sx)
Anticoagulation unless contraindicated – prophylaxis vs tx dose
15. HHS - Monitoring
Fluid balance chart with hourly urine output
IDC if unable to reliably measure
NGT if vomiting and drowsy
Repeat labs
Check 2 hours after initiation of tx then 6 hourly for first 24hrs
BSL/VBG
Hourly obs
If osmolality increases (or falls <3mosmol/kg/hr) and Na increasing check fluid balance
If inadequate: increase infusion rate
If adequate: consider changing to 0.45% saline at same rate
If osmolality falling > 8mosmol/kg/hr consider
Reducing rate of IVF
Reduce rate of insulin infusion
16. HDU/ICU
Consider if:
1. Osmolality >350 mosmol/kg
2. BP < 90mmHg
3. Na > 160mmol/l
4. HR <60 or >100
5. pH <7.1
6. Hypo/hyperkalemia
7. Urine output <0.5 ml/kg/hr
8. GCS <12
9. O2 < 92% RA
10. Other serious co-morbidities
17. References
Pasquel FJ, Umpierrez GE. Hyperosmolar Hyperglycemic State: A Historic Review of the Clinical Presentation, Diagnosis, and Treatment.
Diabetes Care. 2014;37(11):3124-3131. doi:10.2337/dc14-0984.
SCGH Guidelines for the Management of Diabetic Ketoacidosis
SCGH Guidelines for the Management of Hyperosmolar Non-Ketotic Hyperglycemia (HONK)
FSH Adult Diabetic Ketoacidosis (DKA) Guidelines and Management Record
FSH Adult Hyperosmolar Hyperglycaemic State (HHS – formerly known as HONK) Guidelines and Management Record
Dunning, T. 2005 Diabetic ketoacidosis - prevention, management and the benefits of ketone tesing. Director Endocrinology and
Diabetes Nursing Research. St Vincent’s Health & the University of Melbourne. Available
URL:www.reedexhibitions.net.auGPS2006/S11A.ppt-Supplement Result
http://onlinelibrary.wiley.com.qelibresources.health.wa.gov.au/doi/10.1002/14651858.CD011281.pub2/full
Gosmanov AR, Gosmanova EO, Kitabchi AE. Hyperglycemic Crises: Diabetic Ketoacidosis (DKA), And Hyperglycemic Hyperosmolar State
(HHS) [Updated 2015 May 19]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA):
MDText.com, Inc.; 2000-. Available from: https://www-ncbi-nlm-nih-gov.qelibresources.health.wa.gov.au/books/NBK279052/
Scott AR. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med. 2015;32(6):714-24.
Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract.
2011;94(3):340-51.